In HER-2 breast cancer cells, Akt signaling stimulates Rac1 through Rac-GEF Tiam1, and PKC signaling reduces expression of a Rac1 inhibitor, RhoGD12 [334]. The gene discussed is AKT1; the disease is breast carcinoma.